BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 14574513)

  • 1. 11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET.
    Higashi K; Ueda Y; Matsunari I; Kodama Y; Ikeda R; Miura K; Taki S; Higuchi T; Tonami H; Yamamoto I
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):13-21. PubMed ID: 14574513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.
    Henze M; Mohammed A; Mier W; Rudat V; Dietz A; Nollert J; Eisenhut M; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):324-30. PubMed ID: 12002706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring the chemotherapeutic response in primary lung cancer using 99mTc-MIBI SPET.
    Yüksel M; Cermik TF; Karlikaya C; Salan A; Cakir E; Gültekin A; Berkarda S
    Eur J Nucl Med; 2001 Jul; 28(7):799-806. PubMed ID: 11504075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.
    Palmedo H; Bender H; Grünwald F; Mallmann P; Zamora P; Krebs D; Biersack HJ
    Eur J Nucl Med; 1997 Sep; 24(9):1138-45. PubMed ID: 9283107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma.
    Nomori H; Shibata H; Uno K; Iyama K; Honda Y; Nakashima R; Sakaguchi K; Goya T; Takanami I; Koizumi K; Suzuki T; Kaji M; Horio H
    J Thorac Oncol; 2008 Dec; 3(12):1427-32. PubMed ID: 19057268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
    Henze M; Mohammed A; Schlemmer H; Herfarth KK; Mier W; Eisenhut M; Debus J; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1455-61. PubMed ID: 12397464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tc-99m MIBI scintigraphy in patients with lung cancer. Comparison with CT and fluorine-18 FDG PET imaging.
    Wang H; Maurea S; Mainolfi C; Fiore F; Gravina A; Panico MR; Bazzicalupo L; Salvatore M
    Clin Nucl Med; 1997 Apr; 22(4):243-9. PubMed ID: 9099482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-18-2-fluoro-2-deoxyglucose positron emission tomography compared to technetium-99m hexakis-2-methoxyisobutyl isonitrile single photon emission chest tomography in the diagnosis of indeterminate lung lesions.
    Santini M; Fiorelli A; Vicidomini G; Laperuta P; Busiello L; Rambaldi PF; Mansi L; Rotondo A
    Respiration; 2010; 80(6):524-33. PubMed ID: 20881375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
    Tiling R; Linke R; Untch M; Richter A; Fieber S; Brinkbäumer K; Tatsch K; Hahn K
    Eur J Nucl Med; 2001 Jun; 28(6):711-20. PubMed ID: 11440031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer.
    Khan N; Oriuchi N; Zhang H; Higuchi T; Tian M; Inoue T; Sato N; Endo K
    Nucl Med Commun; 2003 Apr; 24(4):359-66. PubMed ID: 12673163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.
    Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Takekoshi N; Tonami N; Hisada K
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1357-64. PubMed ID: 12271419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography.
    Nomori H; Kosaka N; Watanabe K; Ohtsuka T; Naruke T; Kobayashi T; Uno K
    Ann Thorac Surg; 2005 Dec; 80(6):2020-5. PubMed ID: 16305837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Glut-1 glucose transporter expression with.
    Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
    Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11C-acetate for positron emission tomography imaging of clinical stage IA lung adenocarcinoma: comparison with 18F-fluorodeoxyglucose for imaging and evaluation of tumor aggressiveness.
    Shibata H; Nomori H; Uno K; Iyama K; Tomiyoshi K; Nakashima R; Sakaguchi K; Goya T; Takanami I; Koizumi K; Suzuki T; Kaji M; Horio H
    Ann Nucl Med; 2009 Sep; 23(7):609-16. PubMed ID: 19562438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology.
    Piccardo A; Puntoni M; Treglia G; Foppiani L; Bertagna F; Paparo F; Massollo M; Dib B; Paone G; Arlandini A; Catrambone U; Casazza S; Pastorino A; Cabria M; Giovanella L
    Eur J Endocrinol; 2016 May; 174(5):693-703. PubMed ID: 26966173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of beta-oxidation by static PET with 14(R,S)-[18F]-fluoro-6-thiaheptadecanoic acid (FTHA) in patients with advanced coronary heart disease: a comparison with 18FDG-PET and 99Tcm-MIBI SPET.
    Schulz G; von Dahl J; Kaiser HJ; Koch KC; Sabri O; Banneitz L; Cremerius U; Buell U
    Nucl Med Commun; 1996 Dec; 17(12):1057-64. PubMed ID: 9004303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
    Oyama N; Miller TR; Dehdashti F; Siegel BA; Fischer KC; Michalski JM; Kibel AS; Andriole GL; Picus J; Welch MJ
    J Nucl Med; 2003 Apr; 44(4):549-55. PubMed ID: 12679398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11C-acetate PET imaging of prostate cancer.
    Oyama N; Akino H; Kanamaru H; Suzuki Y; Muramoto S; Yonekura Y; Sadato N; Yamamoto K; Okada K
    J Nucl Med; 2002 Feb; 43(2):181-6. PubMed ID: 11850482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.